Skip to main content
SpringerLink
Log in

Huntington’s disease as a model for mood disorders

Clues from neuropathology and neurochemistry

  • Published:
Molecular and Chemical Neuropathology

Abstract

Huntington’s disease (HD) is an inherited neuropsychiatric degenerative process characterized by movement disorder, dementia, and, often, affective disorder (AfD) (seen in 38% of patients). Depression in HD is not just an understandable reaction to fatal illness: 10% of HD patients develop mania; AfD can occur 20 yr before neurological signs; and mood disorders are not randomly distributed, but occur in a subset of HD families. This evidence suggests that AfD in HD relates to brain pathophysiology. With its clear neuropathology, HD is proposed as one model for biological underpinnings of idiopathic AfD. There is striking atrophy and neuronal loss in HD neostriatum, particularly caudate. Caudate has rich connections to the limbic system. It is hypothesized that AfD in HD relates to dysfunction of the part of the neostriatum damaged earliest, dorsal medial caudate. Preliminary studies on neuropathological differences between HD patients with and without AfD are discussed. HD neurochemistry is reviewed, emphasizing the excitotoxin hypothesis, which involves dysfunction of the glutamate neurotransmitter system in HD (especially the NMDA receptor, which contains a channel with a phencyclidine (PCP) binding site). Based on the HD model, it is suggested that the glutamate system (particularly NMDA receptors) be examined in idiopathic AfD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aronin, N., Difiglia, M., Graveland, G. A., et al. (1984) Localization of immunoreactive enkaphalins in GABA synthesizing neurons of the rat neostriatum.Brain Res. 300, 376–380.

    Article  PubMed  CAS  Google Scholar 

  • Aronin, N., Cooper, P. E., Lorenz, I. J., et al. Somatostatin is increased in the basal ganglia in Huntington disease. (1983)Ann. Neurol. 13, 519–526.

    Article  PubMed  CAS  Google Scholar 

  • Beal, M. F. and Martin, J. B. (1986) Neuropeptides in neurological disease.Ann. Neurol. 20, 547–565.

    Article  PubMed  CAS  Google Scholar 

  • Benson, D. F. (1982) The treatable dementias, inPsychiatric Aspects of Neurological Disease, vol. II (Benson D. F. and Blumer D., eds.), Grune and Stratton, NY pp. 123–148.

    Google Scholar 

  • Berger, M., Sperk, G., and Hornykiewicz, O. (1982) Serotonergic denervation partially protects rat striatum from kainic acid toxicity.Nature 299, 254–256.

    Article  PubMed  CAS  Google Scholar 

  • Bernheimer, H. and Hornykiewicz, O. (1973) Brain amines in Huntington’s chorea.Adv. Neurol. 1, 525–531.

    Google Scholar 

  • Bird, E. D. (1979) Huntington’s chorea,Nuerotransmitter Systems and their Clinical Disorders. (Legg N. J., ed.), Academic, London, pp. 143–150.

    Google Scholar 

  • Bird, E. D. (1980) Chemical pathology of Huntington’s disease.Annu. Rev. Pharmacol. Toxicol. 20, 533–551.

    Article  PubMed  CAS  Google Scholar 

  • Bird, E. D. and Iversen, L. L. (1974) Huntington’s chorea: Postmortem measurements of glutamic acid decarboxylase, choline acetyl-transferase and dopamine in basal ganglia.Brain 97, 457–472.

    Article  PubMed  CAS  Google Scholar 

  • Bird, E. D., MacKay, A. V. P., Rayner, C. N., and Iversen, L. L. (1973) Reduced glutamic-acid-decarboxylase activity of postmortem brain in Huntington’s chorea.Lancet 1, 1090–1092.

    Article  PubMed  CAS  Google Scholar 

  • Bruyn, G. W. (1968) Huntington’s chorea. Historical, clinical and laboratory synopsis, inHandbook of Clinical Neurology (Vinken P. J. and Bruyn G. W., eds.), North-Holland, Amsterdam, pp. 298–378.

    Google Scholar 

  • Bruyn, G. W., Bots, G. Th. A. M., and Dom, R. (1979) Huntington’s chorea: Current neuropathological status, inAdvances in Neurology (Chase T. N., Wexler, N. S. and Barbeau, A., eds.) vol. 23, Raven, New York pp. 83–93.

    Google Scholar 

  • Byers, R. K., Gilles, F. H., and Fung, C. (1973) Huntington’s disease in children: Neuropathologic study of four cases.Neurology 23, 561–569.

    PubMed  CAS  Google Scholar 

  • Caine, E. D. and Shoulson, I. (1983) Psychiatric syndromes in Huntington’s disease.Am. J. Psychiatry 140, 728–733.

    PubMed  CAS  Google Scholar 

  • Choi, D. W. (1988) Glutamate neurotoxicity and diseases of the nervous system.Neuron 1, 623–634.

    Article  PubMed  CAS  Google Scholar 

  • Coyle, J. T. and Schwarcz, R. (1976) Lesions of striatal neurons with kainic acid provides a model for Huntington’s chorea.Nature 263, 244–246.

    Article  PubMed  CAS  Google Scholar 

  • Cross, A. J., Slater, P., and Reynolds, G. P. (1986) Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington’s disease.Neurosci. Lett. 67, 199–202.

    Article  Google Scholar 

  • Crow, T. W. (1982) The biology of schizophrenia.Experientia 38, 1275.

    Article  PubMed  CAS  Google Scholar 

  • Dawbarn, D., De Quidt, M. E., and Emson, P. C. (1985) Survival of basal ganglia neuropeptide Y-somatostatin neurons in Huntington’s disease.Brain Res. 340, 251–260.

    Article  PubMed  CAS  Google Scholar 

  • De La Monte, S. M., Vonsattel, J-P., and Richardson, E. P. (1988) Morphometric demonstration of atrophic changes in the cerebral cortex, white matter and neostriatum in Huntington’s disease.J. Neuropathol. Exp. Neurol. 47, 516–525.

    Article  PubMed  Google Scholar 

  • DeFelipe, M. C., DeCedallos, N. L., Gil, C., and Fuentes, J. A. (1985) Chronic antidepressant treatment increases enkephalin levels in nucleus accumbens and striatum of the rat.Eur. J. Pharmacol. 112, 119–122.

    Article  CAS  Google Scholar 

  • Dening, T. R. and Berrids, G. E. (1989) Wilson’s disease: Psychiatric symptoms in 195 patients.Arch. Gen. Psych. 46, 1126–1134.

    CAS  Google Scholar 

  • Difiglia, M., Aronin, N. and Martin, J. B. (1982) Light and electron microscopic localizations of immunoreactive leu-enkephalin in the monkey basal gangliaJ. Neurosci. 2, 303–320.

    PubMed  CAS  Google Scholar 

  • Dom, R. (1976)Neostriatal and Thalamic Interneurons. Their Role in the Pathophysiology of Huntington’s Chorea, Parkinson’s Disease and Catatonic Schizophrenia (Acco, Leuven).

  • Dom, R., Baro, F. and Bruchner, J. M. (1973) A cytometric study of the putamen in different types of Huntington’s chorea, inHuntington’s Chorea, 1872–1972 (Barbeau, A., Chase, T. N., and Paulson, G. W., eds.), Raven, New York pp. 369–385.

    Google Scholar 

  • Dom, R., Malfroid, M., and Baro, F. (1976b) Neuropathology of Huntington’s chorea: Cytometric studies of the ventrobasal complex of the thalamus.Neurology 26, 64–68.

    PubMed  CAS  Google Scholar 

  • Emson, P. C., Arregui, A., Clement-Jones, V., Sandberg, B. E. B., and Rossor, M. (1980) Regional distribution of methionine-enkephalin and substance-P like immunoreactivity in normal brain and in Huntington’s disease.Brain Res. 198, 497–500.

    Article  PubMed  CAS  Google Scholar 

  • Enna, S. J. (1981) Neuropharmacological and clinical aspects of gamma-aminobutyric acid (GABA), inNeuropharmacology of Central Nervous System and Behavioral Disorders (Palmer, G., ed.), Academic, New York.

    Google Scholar 

  • Ettenburg, A., Pettit, H. O., Bloom, F. E., and Koob, G. F. (1982) Heroin and cocaine intravenous self-administration in rats: Mediation by separate neural systems.Psychopharmacology 78, 204–209.

    Article  Google Scholar 

  • Feigenbaum, L. A., Graybiel, A. M., Vonsattel, J. P., Richardson, E. P., and Bird, E. D. (1986) Striosomal markers in the striatumin Huntington’s disease.Soc. Neurosci. Abstracts 12.

  • Ferrante, R. J., Kowall, N. W., Beal, M. F., Richardson, E. P., Bird, E. D., and Martin, J. B. (1985) Selective sparing of a class of striatal neurons in Huntington’s disease.Science 230, 561–563.

    Article  PubMed  CAS  Google Scholar 

  • Ferrante, R. J., Kowall, N. W., Richardson, E. P., Bird, E. D., and Martin, J. B. (1986) Topography of enkephalin, substance P and acetylcholinesterase staining in Huntington’s disease striatum.Neurosci. Lett. 71, 283–288.

    Article  PubMed  CAS  Google Scholar 

  • Ferrante, R. J., Kowall, N. W., Beal, M. F., et al. (1987) Morphological and histochemical characteristics of a spared subset of striatal neurons in Huntington’s disease.J. Neuropathol. Exp. Neurol. 46, 12–27.

    Article  PubMed  CAS  Google Scholar 

  • Folstein, S. E. (in press) Disease of the cuadate: A model of manic depressive disorder, inFunction and Dysfunction of the Basal Ganglia (Franks et al., eds.), Manchester University Press, Manchester, England.

  • Folstein, S. E., Folstein, M. F., and McHugh, P. R. (1979) Psychiatric syndromes in Huntington’s disease, inAdvances in Neurology (Chase, T. N., Wexler, N. S., and Barbeau, A., eds.), Raven, New York, pp. 281–289.

    Google Scholar 

  • Folstein, S. E., Abbott, M. H., Chase, G. A., Jensen, B. A., and Folstein, M. F. (1983a) The association of affective disorder with Huntington’s disease in case series and in families.Psychol. Med. 13, 537–542.

    Article  PubMed  CAS  Google Scholar 

  • Folstein, S. E., Franz, M. L., Jensen, B., Chase, G. A., and Folstein, M. F. (1983b) Conduct disorder and affective disorder among the offspring of patients with Huntington’s disease, inChildhood Psychopathology and Development (Guze, F., Earls, J., and Barrett, J. E., eds.), Raven, New York, pp. 231–245.

    Google Scholar 

  • Folstein, S. E., Abbott, M. H., Franz, M. L., Huang, S., Chase, G. A., and Folstein, M. F. (1984) Phenotypic heterogeneity in Huntington’s disease.J. Neurogenetic.,1, 175–184.

    Article  CAS  Google Scholar 

  • Folstein, S. E., Leigh, R. J., Parhad, I. M., and Folstein, M. F. (1986) The diagnosis of Huntington’s disease.Neurology 36, 1279–1283.

    PubMed  CAS  Google Scholar 

  • Folstein, S. E., Chase, G. A., Wahl, W. E., McDonnell, A. M., and Folstein, M. F. (1987) Huntington’s disease: Clinical aspects of racial variation.Amer. J. Hum. Genet. 41, 168–179.

    PubMed  CAS  Google Scholar 

  • Gerfen, C. R. (1984) The neostriatal matrix: Compartmentalization of corticostriatal input and striatonigral output systems.Nature 311, 461–464.

    Article  PubMed  CAS  Google Scholar 

  • Gerfen, C. R. (1986) The developmental and biochemical basis of dual “patch” and “matrix” nigrostriatal dopaminergic systems in the rat.Neurosci. Abst 362.8.

  • Gerfen, C. R., Baimbridge, K. G., and Thibault, J. (1987a) The neo-striatal mosaic: III Biochemical and developmental dissociation of patch-matrix striatal systems.J. Neurosci. 7, 3935–3944.

    PubMed  CAS  Google Scholar 

  • Gerfen, C. R., Herkenham, M., and Thibault, J. (1987b) The neostriatal mosaic: II Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems.J. Neurosci. 7, 3915–3934.

    PubMed  CAS  Google Scholar 

  • Graybiel, A. M. and Ragsdale, C. W. (1978) Histochemically distinct compartments in the striatum of human, monkey and cat demonstrated by acetylcholiesterase staining.Proc. Natl. Acad. Sci. USA 75, 5723–5726.

    Article  PubMed  CAS  Google Scholar 

  • Graybiel, A. M., and Ragsdale, C. W. (1983) Biochemical anatomy of the human striatum,Chemical Neuroanatomy (Emson, P. C., ed.) Raven, New York pp. 427–504.

    Google Scholar 

  • Gusella, J. F., Wexler, N. S., Conneally, P. M., Naylor, S. L., Anderson, M. A., Tanzi, R. E., Watkins, P. C., Ottina, K., Wallace, M. R., Sakaguchi, A. Y., Young, A. B., Shoulson, I., Bonilla, E., and Martin, J. B. (1983) A polymorphic DNA marker genetically linked to Huntington’s disease.Nature 306, 234–238.

    Article  PubMed  CAS  Google Scholar 

  • Hoehn-Saric R. (1982) Neurotransmitters in anxiety.Arch. Gen. Psychiatry 39, 635–642.

    Google Scholar 

  • Huber, S. J., Paulson, G. W., and Shuttleworth, E. C. (1988) Depression in Parkinson’s disease.Neuropsychiatr. Neuropsychol. Behav. Neurol. 1, 47–51.

    Google Scholar 

  • Hunt, J. R. (1917) Progressive atrophy of the globus pallidus. (Primary atrophy of the pallidal system) A system disease of the paralysis agitans type, characterized by atrophy of the motor cells of the corpus striatum: A contribution to the funcitons of the corpus striatum.Brain 40, 58–148.

    Article  Google Scholar 

  • Huntington, G. (1872) On chorea.Adv. Neurol. 1, 33–35.

    Google Scholar 

  • Iversen, L. L., Rosser, M. N., and Reynolds, G. P. (1983) Loss of pigmented dopamine-β-hydrosylase positive cells from locus coeruleus in senile dementia of Alzheimer’s type.Neurosci. Lett. 39, 95–100.

    Article  PubMed  CAS  Google Scholar 

  • Kane, J., Struve, F., Weinhold, P., et al. (1980) Strategy for the study of patients at high risk for tardive dyskinesia.Am. J. Psychol. 137, 1265–1267.

    CAS  Google Scholar 

  • Kemp, J. A., Foster, A. C., and Wong, E. H. F. (1987) Non-competitive antagonists of excitatory amino acid receptors.TINS,10, 294–298.

    CAS  Google Scholar 

  • Kiesselbach, G. (1914) Anatomischer Befund eines Falles von Huntingtonischer Chorea. Mschr.Psychiatr. Neurol. 35, 525–543.

    Article  Google Scholar 

  • Kish, S. J., Shannak, K. S., and Hornykiewicz, O. (1987) Elevated serotonin and reduced dopamine in subregionally divided Huntington’s disease striatum.Ann. Neurol. 22, 386–389.

    Article  PubMed  CAS  Google Scholar 

  • Kurlan, R., Caine, E., Rubin, A., Nemeroff, C. B., Bissette, G., Zaczek, R., Coyle, J., Spielman, F. J., Irvine, D., and Shoulson, I. (1988) Cerebrospinal fluid correlates of depression in Huntington’s disease.Arch. Neurol. 45, 881–883.

    PubMed  CAS  Google Scholar 

  • Lange, H. W. (1981) quantitative changes of telencephalon, diencephalon, and mesencephalon in Huntington’s chorea, post-encephalitic and idiopathic Parkinsonism.Verh. Anat. Ges. 75, 923–125.

    Google Scholar 

  • Lange, H. and Thorner, G. (1974) Zur Neuroanatomie and Neuropathologie des Corpus Striatum, Globus Pallidus und Nucleus Subthalamicus beim Mefxhen. Eine morphometrischstatistische Strukturanalyse at 13 Normal- und 15 Choreage-hirnen (unpublished).

  • Lange, H., Thorner, G., Hopf, A., and Schroeder, K. F. (1976) Morphometric studies of the neuropathological changes in choreatic diseases.J. Neurol. Sci. 28, 401–425.

    Article  PubMed  CAS  Google Scholar 

  • Lloyd, K. G., Thuret, F., and Pilc, A. (1985) Upregulation of Gamma-aminobutyric acid (GABA) B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electro-shock.J. Pharmacol. Exp. Ther. 235, 191–199.

    PubMed  CAS  Google Scholar 

  • Lloyd, K. G., Zivkovic, B., Scatton, B., Morselli, P. L., and Bartholini, G. (1989) The GABAergic hypothesis of depression.Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 13, 341–351.

    Article  CAS  Google Scholar 

  • Lodge, D., Aram, J. A., Church, J., Davies, S. N., Martin, D., O’Shaughnessy, C. T., and Zeman, S. (1987) Excitatory aminoacids and PCP like drugs.Neurol. Neurobiol. 24, 83–90.

    CAS  Google Scholar 

  • Lucas, D. R. and Newhouse, P. (1957) The toxic effect of sodiuml-glutamate on the inner layers of the retins.Arch. Opthalmol. 58, 193–201.

    CAS  Google Scholar 

  • Malick, J. B., Enna, S. J., and Yamamura, H. I. (1983)Anxiolytics: Neurochemical, Behavioral and Clinical Perspectives, Raven, New York.

    Google Scholar 

  • Marshall, P. E., Landis, D. M. D., and Zalneraitis, E. (1983) Immunocytochemical studies of substance P and leucine-enkephalinin Huntington’s disease.Brain Res. 298, 11–26.

    Article  Google Scholar 

  • Martin, J. B. (1984) Huntington’s disease: New approaches to an old problem.Neurology 34, 1059–1072.

    PubMed  CAS  Google Scholar 

  • Mazziotta, J. C., Phelps, M. E., Pahl, J. J., et al. (1987) Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington’s disease. inEng. J. Medicine 316, 357–362.

    Google Scholar 

  • McCaughey, W. T. E. (1961) The pathological spectrum of Huntington’s chorea.J. Nerv. Ment. Dis. 133, 91–103.

    Google Scholar 

  • McGeer, E. G., and McGeer, P. L. (1976) Duplication of biochemical changes of Huntington’s chorea,Progress in Neurogenetics (Barbeau A. and Brunette T. R., eds.) Excerpta Medica Foundation, Amsterdam pp. 645–650.

    Google Scholar 

  • McHugh, P. R. (in press) The Basal Ganglia: The region, the integration of its systems and implications for psychiatry and neurology, inFunction and Dysfunction of the Basal Ganglia (Franks et al., eds) Manchester University Press, Manchester, England

  • McHugh, P. R. and Folstein, M. F. (1975) Psychiatric syndromes of Huntington’s chorea: A clinical and phenomenologic study, inPsychiatric Aspects of Neurologic Disease (Benson D. F. and Blumer, D., eds.) Grune and Stratton, New York.

    Google Scholar 

  • Melamed, E., Hefti, F., and Bird, E. D. (1982) Huntington chorea is not associated with hyperactivity of nigrostriatal dopaminergic neurons: Studies in postmortem tissues and in rats with kainic acid lesions.Neurology 32, 640–644.

    PubMed  CAS  Google Scholar 

  • Minski, L. and Guttman, E. (1938) Huntington’s chorea: A study of thirty-four families.J. Ment. Sci. 84, 21–96.

    Google Scholar 

  • Morselli, P. L., Priore, P., Loeb, C., Albano, C., Nielsen, N. P., Serrati, C., and Musch, B. (1988) Antidepressant activity of progabide and fengabine, inNew Directions in Affective Disorders (Lerer, B. and Gershon, S., eds.). Springer-Verlag, NY.

    Google Scholar 

  • Nakata, Y., Chang, K. J., Mitchell, C. L., and Hong, J. S. (1985) Repeated electroconvulsive shock down regulates the opioid receptors in rat brain.Brain Res. 346, 160–163.

    Article  PubMed  CAS  Google Scholar 

  • Nauta, W. J. H. and Domesick, V. B. (1981) Ramifications of the limbic system,Psychiatry and Biology of the Human Brain (Matthysse S., ed.) Elsevier North Holland Biomedical, New York.

    Google Scholar 

  • Nauta, H. J. W. (1986) The relationship of the basal ganglia to the limbic system,Extrapyramidal Disorders (Vinken P. J., Bruyn, G. W., and Klawans H. L., eds.) Elsevier Science, New York pp. 19–31.

    Google Scholar 

  • Nauta, W. J. H. and Feirtag, M. (1986)Fundamental Neuroanatomy. Freeman, New York.

    Google Scholar 

  • Nemeroff, C. B., Youngblood, W. W., Manberg, P. J., et al. (1983) Regional brain concentrations of neuropeptides in Huntington’s chorea and schizophrenia.Science 221, 972–975.

    Article  PubMed  CAS  Google Scholar 

  • Olney, J. W. (1969) Glutamate-induced retinal degeneration in neonatal mice: Electronmicroscopy of acutely evolving lesions.J. Neuropathol. Exp. Neurol. 28, 455–474.

    Article  PubMed  CAS  Google Scholar 

  • Oyanagi, K., Takeda, S., Takahashi, H., Ohama, E., and Ikuta, F. (1989) A quantitative investigation of the substantia nigra in Huntington’s disease.Ann. Neurol. 26, 13–19.

    Article  PubMed  CAS  Google Scholar 

  • Pasik, P., Pasik, T. and DiFiglia, M. (1979) The internal organization of the neostriatum in mammals, inThe Neostriatum (Divac J. and Oberg R. G., eds.) pp. 5–36.

  • Penney, Jr., J. B. and Young, A. B. (1982) Quantitative autoradiography in neurotransmitter receptors in Huntington disease.Neurology 32, 1391–1395.

    PubMed  Google Scholar 

  • Perry, T. L., Hansen, S. and Kloster, M. (1973) Huntington’s chorea: Deficiency of gamma-aminobutyric acid in brain.N. Engl. J. Med. 288, 337–342.

    Article  PubMed  CAS  Google Scholar 

  • Rabins, P. (1982) The psychopathology of Parkinson’s disease.Compr. Psychiatry 23, 421–428.

    Article  PubMed  CAS  Google Scholar 

  • Reiner, A., Albin, R. L., Anderson, K. D., D’Amato, C. J., Penney, J. B., and Young, A. B. (1988) Differential loss of striatal projection neurons in Huntington’s disease.Proc. Natl. Acad. Sci. USA,85, 5733–5737.

    Article  PubMed  CAS  Google Scholar 

  • Ribak, C. E., Vaughn, J. E., and Roberts, E. (1979) The GABA neurons and their axon terminals in the rat corpus striatum as demonstrated by GAD immunocytochemistry.J. Comp. Neurol. 187, 267–284.

    Article  Google Scholar 

  • Robinson, M. B. and Coyle, J. T. (1987) Glutamate and related acidic excitatory neurotransmitters: From basic science to clinical application.Fed Soc. Exp. Biol. 1, 446–455.

    CAS  Google Scholar 

  • Rodda, R. A. (1981) Cerebellar atrophy in Huntington’s disease.J. Neurol. Sci. 50, 147–157.

    Article  PubMed  CAS  Google Scholar 

  • Schwarcz, R., Kohler, C., Mangano, R. M., and Neophytides, A. N. (1981) Glutamate-induced neuronal degeneration: Studies on the role of glutamate re-uptake, inGlutamate as a Neurotransmitter (DiChiara, G. D. and Gessa, G. L. eds.)27, 403–412.

  • Shoulson, I., Chase, T. N., Roberts, E., and Van Balgooy, J. N. (1975) Huntington’s disease: treatment with imidazole-4-acetic acid.N. Engl. J. Med. 293, 504, 505.

    PubMed  CAS  Google Scholar 

  • Shoulson, I., Kartzinel, R., and Chase, T. N. (1976) Huntington’s disease: Treatment with dipropylacetic acid and gamma-aminobutyric acid.Neurology 26, 61–63.

    PubMed  CAS  Google Scholar 

  • Spokes, E. G. S. (1980) Neurochemical alterations in Huntington’s chorea: A study of postmortem brain tissue.Brain 103, 179–210.

    Article  PubMed  CAS  Google Scholar 

  • Trautner, R. J., Cummings, J. L., Read, S. L., and Benson, D. F. (1988) Idiopathic basal ganglia calcification and organic mood disorder.Am. J. Psychiatry 145, 350–353.

    PubMed  CAS  Google Scholar 

  • Vonsattel, J. P., Meyers, R. H., Stevens, T. J., Ferrante, R. J., Bird, E. D., and Richardson, E. P., Jr. (1985) Neuropathological classification of Huntington’s disease.J. Neuropathol. Exp. Neurol. 44, 559–577.

    Article  PubMed  CAS  Google Scholar 

  • Wexler, N. S., Young, A. B., Tanzi, R. E., Travers, H., Starosta-Rubinstein, S., Penney, J. B., Snodgrass, S. R., Shoulson, I., Gomez, F., Ramos, A., Penchaszadeh, G. K., Moreno, U., Gibbons, K., Faryniarz, A., Hobbs, W., Anderson, M. A., Bonilla, E., Conneally, T. M., and Guzella, J. F. (1987) Homozygotes for Huntington’s disease.Nature 326, 194–197.

    Article  PubMed  CAS  Google Scholar 

  • Whitehouse, P. J., Jones, B. E., Trifiletti, R. R., Folstein, S. E., Price, D. L., and Kuhar, M. J. (1985) Neurotransmitter receptor alterations in Huntington’s disease: Autoradiographic studies.Ann. Neurol.,18, 202–210.

    Article  PubMed  CAS  Google Scholar 

  • Wolfe, J., Granholm, E., Butters, N., Saunders, E., and Janowsky, D. (1987) Verbal memory deficits associated with major affective disorders: a comparison of unipolar and bipolar patients.J. Aff. Dis. 13, 83–92.

    Article  CAS  Google Scholar 

  • Young, A. B., Greenamyre, J. T., Hollingswoth, Z., Albin, R., D’Amato, C., Shoulson, I., and Penney, J. B. (1988) NMDA receptor losses in putamen from patients with Huntington’s disease (HD)Science 241, 981–983.

    Article  PubMed  CAS  Google Scholar 

  • Young, A. B., Pan, H. S., Ciliax, B. J., and Penney, J. B. (1984) GABA and Benzodiazepine receptors in basal ganglion function.Neurosci. Lett. 47, 361–367.

    Article  PubMed  CAS  Google Scholar 

  • Young, A. B., Penney, J. B., Starosta-Rubenstein, S., Markel, B., Berent, S., Rothley, J., Betley, A., and Hickwa, R. (1987) Normal caudate glucose metabolism in persons at risk for Huntington’s disease.Arch. Neurol. 44, 254–257.

    PubMed  CAS  Google Scholar 

  • Zech, M., Roberts, G. W., Bogerts, B., Crow, T. J., and Polak, J. M. (1986) Neuropeptides in the amygdala of controls, schizophrenics and patients suffering from Huntington’s chorea: An immunohistochemical study.Acta Neuropathol. 71, 259–266.

    Article  PubMed  CAS  Google Scholar 

  • Zweig, R. M., Ross, C. A., Hedreen, J. C., et al. (1988) The neuropathology of aminergic nuclei in Alzheimer’s disease.Ann. Neurol. 24, 233–242.

    Article  PubMed  CAS  Google Scholar 

  • Zweig, R. M., Ross, C. A., Hedreen, J. C., Peyser, C. E., Cardillo, J. E., Cohen, M., Folstein, S. E., and Price, D. L. (1989) Clinical and pathological correlates of locus coeruleus pathology in Parkinson’s disease and Huntington’s disease.Soc. Neurosci. Abstracts 369.1, 931.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Johns Hopkins University of School of Medicine, 21205, Baltimore, MD

    Carol Efron Peyser & Susan E. Folstein

Authors
  1. Carol Efron Peyser
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susan E. Folstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Peyser, C.E., Folstein, S.E. Huntington’s disease as a model for mood disorders. Molecular and Chemical Neuropathology 12, 99–119 (1990). https://doi.org/10.1007/BF03160062

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03160062

Index Entries

Search

Navigation